EQS-News: Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis
EQS-News: ABIVAX / Key word(s): Study results Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance tri...